Surveillance of antimicrobial resistance could be more challenging outside of the EU
22 December 2020
In a new report from the Microbiology Society, experts from around the UK explain the desperate need for long-term and ambitious funding for surveillance and research into antimicrobial resistance (AMR).
The next pandemic is likely to be associated with antimicrobial resistance, they say, and improved surveillance systems to monitor the evolution of AMR over time will be critical to avoid a surge in drug-resistant infections.
Further reading: EurekAlert
Author(s): EurekAlert
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
